Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Researchers sought to determine whether CAR-T therapy could improve HR-QoL scores for patients with relapsed or refractory multiple myeloma.

A Harrisburg grandfather bikes thousands of miles a yearfighting against his multiple myeloma cancer. CBS 21’s Alex Thill sat ...

A major European study of 2,446 patients shows that circulating tumour cells (CTCs) are a powerful, independent predictor of ...

By the time her cancer was caught, six months after her symptoms began and two days after her 46th birthday, Louise Greenbank ...

Paul Silvester, from Sheffield, was diagnosed with Myeloma in July 2023 after his cancer caused broken vertebrae in his spine ...

A Sheffield man has become one of the first patients in the world to benefit from a pioneering therapy that could halt the ...

Terminal patients could get years more with their loved ones as the NHS offers Blenrep, which can put some blood cancer patients in remission ...

The NHS in England will be the first health system in the world to roll-out a ‘trojan horse’ targeted therapy for blood cancer patients which could halt the disease’s progression by nearly three times ...

In a collaborative effort spearheaded by the International Myeloma Society (IMS), global myeloma thought leaders published the first consensus definition of high-risk multiple myeloma in the ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and ...

Multiple myeloma affects bone marrow, can cause bones to become brittle, and can also affect various parts of the body, such as the spine, skull, pelvis, and ribs. Sharn's pain lasted for 12 weeks, ...